Diasome appoints HBG team to serve as senior executives

Diasome Pharmaceuticals is strengthening its management team. Health Business Group is providing a team to lead strategy, business development and commercial. Biospace (Diasome Pharmaceuticals Strengthens Leadership Team as Company Prepares for Phase 3 Development) carried the announcement.

“The Health Business Group team is a key component of Diasome’s expansion as a company. HBG’s deep experience in life sciences strategy, market access analysis and business development enables us to extend our reach as we finalize our phase 3 HDV-Insulin plans and look towards commercialization,” said Robert Geho, Chief Executive Officer of Diasome Pharmaceuticals.